国产在线一区二区三区AV,国产AV天堂无码一区二区三区,黄色电影免费观看,国内精品久久久久久99蜜桃

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

亚洲精品国产精华液| 在线看国产一区二区三区| 国产亚洲精品久久久久久国模美| 人妻被中出不敢呻吟a片视频| 欧美亚洲精品SUV| 国产精品无码亚洲精品2021| 永久免费无代码开发平台网站| 野花日本大全免费视频720| 亚洲国产一区二区三区在线观看| 亚洲视频在线观看| AV无码精品一区二区三区| 男女真人抽搐一进一出免费视频| 国产偷V国产偷V国产高清| 无码熟妇人妻AV在线影片最多| CAOPORN国产精品免费视频| 亚洲精品无码av久久久久久| 人妻无码ΑV中文字幕久久琪琪布| 久久av高潮av无码av| 亚洲色在线无码国产精品不卡| 激情 人妻 制服 丝袜| 中文字幕久久久人妻无码 | 人妻出轨和黑人疯狂做国产人| 无码人妻AⅤ一区二区三区蜜桃| 久久亚洲AV无码国产精品| 日韩精品无码中文字幕第一区| 欧美最猛性XXXXXX| 久久久久久人妻毛片a片| 一区二区亚洲AV天堂嫩模| 亚洲精品国产精品国自产| 人人妻人人爽人人澡欧美一区| 成人国内精品久久久久影院 | 亚洲国产另类久久久精品黑人| 人妻办公室出轨上司hd院线| 久久人人爽人人爽人人片av麻烦| a片人人澡c片人人人妻| 亚洲最大成人网| 性色A∨亚洲一区二区三区 | 免费看污又色又爽又黄又脏小说| 久久精品国产久精国产| 亚洲精品女同中文字幕| 免费av在线观看|